AD26.COV2.S: 433 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
433
Total FAERS Reports
17 (3.9%)
Deaths Reported
115
Hospitalizations
433
As Primary/Secondary Suspect
9
Life-Threatening
3
Disabilities
First Report: 20160101 · Latest Report: 20241106
What Are the Most Common AD26.COV2.S Side Effects?
#1 Most Reported
Covid-19
58 reports (13.4%)
#2 Most Reported
Fatigue
47 reports (10.9%)
#3 Most Reported
Off label use
43 reports (9.9%)
All AD26.COV2.S Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Covid-19 | 58 | 13.4% | 0 | 18 |
| Fatigue | 47 | 10.9% | 0 | 12 |
| Off label use | 43 | 9.9% | 0 | 13 |
| Headache | 42 | 9.7% | 0 | 6 |
| Pain | 41 | 9.5% | 0 | 18 |
| Pyrexia | 40 | 9.2% | 0 | 11 |
| Malaise | 38 | 8.8% | 0 | 12 |
| Arthralgia | 32 | 7.4% | 0 | 11 |
| Chills | 31 | 7.2% | 0 | 8 |
| Nausea | 25 | 5.8% | 0 | 9 |
| Pain in extremity | 24 | 5.5% | 1 | 5 |
| Covid-19 immunisation | 22 | 5.1% | 0 | 6 |
| Diarrhoea | 21 | 4.9% | 0 | 8 |
| Drug ineffective | 20 | 4.6% | 0 | 4 |
| Feeling abnormal | 20 | 4.6% | 0 | 3 |
| Vaccination failure | 20 | 4.6% | 0 | 2 |
| Illness | 19 | 4.4% | 0 | 5 |
| Rash | 19 | 4.4% | 0 | 1 |
| Suspected covid-19 | 18 | 4.2% | 0 | 2 |
| Myalgia | 17 | 3.9% | 0 | 5 |
Who Reports AD26.COV2.S Side Effects? Age & Gender Data
Gender: 65.7% female, 34.3% male. Average age: 53.3 years. Most reports from: US. View detailed demographics →
Is AD26.COV2.S Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 0 | 3 |
| 2018 | 1 | 0 | 1 |
| 2019 | 9 | 0 | 2 |
| 2020 | 17 | 0 | 5 |
| 2021 | 187 | 13 | 62 |
| 2022 | 56 | 0 | 15 |
| 2023 | 14 | 0 | 8 |
| 2024 | 3 | 0 | 0 |
What Is AD26.COV2.S Used For?
| Indication | Reports |
|---|---|
| Covid-19 immunisation | 190 |
| Immunisation | 113 |
| Covid-19 prophylaxis | 64 |
| Product used for unknown indication | 37 |
AD26.COV2.S vs Alternatives: Which Is Safer?
AD26.COV2.S vs ADAGRASIB
AD26.COV2.S vs ADALIMUMAB
AD26.COV2.S vs ADALIMUMAB-AACF
AD26.COV2.S vs ADALIMUMAB-AATY
AD26.COV2.S vs ADALIMUMAB-ADAZ
AD26.COV2.S vs ADALIMUMAB-ADBM
AD26.COV2.S vs ADALIMUMAB-AFZB
AD26.COV2.S vs ADALIMUMAB-ATTO
AD26.COV2.S vs ADALIMUMAB-BWWD
AD26.COV2.S vs ADALIMUMAB-FKJP
Official FDA Label for AD26.COV2.S
Official prescribing information from the FDA-approved drug label.